Publications

Back to Publications

Stay up to date with our literature reviews which are curated by experts to feature the most important publications released each month. Explore our publications for access to concise summary slides for your own use.

Finerenone in patients with CKD and T2D with and without heart failure: A prespecified subgroup analysis of the FIDELIO-DKD trial

PMID: 35239204 DOI: 10.1002/ejhf.2469

The effects of finerenone on cardiorenal outcomes in patients with chronic kidney disease and type 2 diabetes were compared in this prespecified analysis of the FIDELIO-DKD trial. The patients (none of whom had symptomatic HFref) were treated with optimised renin-angiotensin system blockade and were randomised to finerenone or placebo.


LinkedIn